Trial Profile
Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary)
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 25 Dec 2014 New trial record